J Rovenský

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Josef S Smolen, André Beaulieu, Andrea Rubbert‐Roth et al. · The Lancet · 2008 · 1.4K citations

Medicine, Immunology, Pharmacology +16

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Jos N. Hoes, Johannes W. G. Jacobs, Maarten Boers et al. · Annals of the Rheumatic Diseases · 2007 · 408 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

Nneoma Duru, Marlies C. van der Goes, J. W. G. Jacobs et al. · Annals of the Rheumatic Diseases · 2013 · 270 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome.

Elias Toubi, Ilan Krause, Abigail Fraser et al. · PubMed · 2005 · 82 citations

Medicine, Hematology, Pathology +12

The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome

Ilan Krause, Miri Blank, Abigail Fraser et al. · Immunobiology · 2005 · 80 citations

Medicine, Hematology, Immunology +14